Skip to main content

Foghorn Therapeutics Inc.

FHTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001822462

No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Foghorn Therapeutics Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of FHTX: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders6061+1
Shares24.2M24.9M+681.1K (+2.8%)
Value$553.5M$379.1M−$174.4M (−31.5%)

New holders (12)

Institutions that held Foghorn Therapeutics Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to FHTX in Q1 2022
InstitutionSharesValue% of portfolio
Deerfield Management Company, L.P. (Series C)238,865$3.64M0.08%
Citadel Advisors LLC58,546$892.0K0.00%
Dimensional Fund Advisors LP19,758$300.0K0.00%
NewSquare Capital LLC10,000$152.0K0.02%
Barclays PLC3,178$48.0K0.00%
Amalgamated Bank2,501$38.0K0.00%
Amalgamated Financial Corp.2,501$38.0K0.00%
High Net Worth Advisory Group LLC500$8.00K0.00%
Signaturefd, LLC184$3.00K0.00%
Captrust Financial Advisors100$2.00K0.00%
Glassman Wealth Services53$1.00K0.00%
State of Wyoming3$00.00%

Sold out (11)

Institutions that held Foghorn Therapeutics Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of FHTX in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Monashee Investment Management LLC240,000$5.49M
EAM Investors, LLC149,280$3.41M
EAM Global Investors LLC103,241$2.36M
Parametric Portfolio Associates LLC62,663$1.43M
Jane Street Group, LLC46,638$1.07M
SEI Investments Co38,464$880.0K
Sunbelt Securities, Inc.24,740$334.0K
Manufacturers Life Insurance Company, The10,246$234.0K
SG3 Management, LLC5,000$114.0K
SG Americas Securities, LLC4,624$106.0K
Quadrant Capital Group LLC89$2.00K